Based on their five and ten year figures for breast cancer free survival and overall survival after ovarian cancer, the authors suggest non-surgical management of breast cancer risk in women with a BRCA1/BRCA2-associated ovarian cancer. This evidence concerns the gene BRCA2 and breast cancer.